Close Menu

protein biomarkers

NEW YORK (GenomeWeb News) – Vermillion has signed a cooperative research and development agreement, or CRADA, with the US Army Medical Research and Materiel Command for the evaluation of the OVA1 ovarian cancer diagnostic test, Vermillion announced today.

BG medicine is hopeful that data from two studies published earlier this year will help shore up the scientific foundation for the company's new strategy of marketing its galectin-3 test to hospitals as a tool for reducing unplanned readmissions.

NEW YORK (GenomeWeb News) – Drug firm Summit and the Children's National Medical Center in Washington today announced a collaboration for the development of a proteomic assay to measure biomarkers in support of Summit's candidate drug for Duchenne Muscular Dystrophy (DMD).

NEW YORK (GenomeWeb News) – Maternal and fetal biotechnology firm Carmenta Bioscience today said it has acquired an option for a worldwide, exclusive license from Stanford University for technology aimed at diagnosing and predicting preeclampsia.

A team of researchers at Boston Children's Hospital has identified a pair of urine biomarkers — filamin C and meprin A — that could be the first to provide accurate early diagnosis of Kawasaki disease.

NEW YORK (GenomeWeb News) – Trovagene today announced it has granted to Genoptix a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia.

NEW YORK (GenomeWeb News) – Opko Health has acquired Prost-Data, a Nashville, Tenn.-based CLIA laboratory doing business under the name OURLab.

NEW YORK (GenomeWeb News) – Aushon BioSystems said today that it has appointed AH Diagnostics to be its exclusive distributor in Scandinavia, effective immediately.

NEW YORK (GenomeWeb News) – BG Medicine today announced a deal with Kindstar Diagnostics to offer galectin-3 testing services in China.

Diagnostics company 20/20 GeneSystems presented data last week showing high sensitivity and specificity for its protein biomarker test to predict response to Herceptin (trastuzumab) in HER2-positive breast cancer patients.

Pages

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.